Scheme Rejected – Gabs Investments and Ajanta Pharma Merger
On 7 th of September, the NCLT Mumbai bench, rejected the scheme of amalgamation and arrangement between Gabs Investments Pvt Ltd (Gabs) – the TRANSFEROR Company and Ajanta Pharma Ltd (Ajanta Pharma) – the TRANSFEREE Company and their respective shareholders on the grounds of General Anti Avoidance Rules (GAAR). Facts and background Gabs Investment is a private limited investment company and Ajanta Pharma is a listed, pharmaceutical company. While the entire shareholding of Gabs Investments is held by Agrawal Family Members (Promoters), both Gabs Investments and Agrawal Family Members are shareholders and promoters of Ajanta Pharma. In the present Scheme, Gabs Investments was proposed to be merged into Ajanta Pharma, with shares to be allotted to the shareholders of Gabs Investments. Gabs Investment Pvt Ltd(Gabs) is the group holding company and primarily holds 9.53% stake in Transferee company. Consequently, the shareholding of Gabs Investments in Ajanta Pharma would have...